[Commentary]: The serotonin transporter in depression: Meta-analysis of in vivo and post mortem findings and implications for understanding and treating depression
Cumming, Paul, Gryglewski, Gregor, Kranz, Georg S., & Lanzenberger, Rupert (2016) [Commentary]: The serotonin transporter in depression: Meta-analysis of in vivo and post mortem findings and implications for understanding and treating depression. Journal of Affective Disorders, 199, pp. 21-22.
Meta-analyses are one of the cornerstones of evidence-based medicine. This is especially true as pertains to clinical molecular imaging studies by single photon computed tomography (SPECT) and positron emission tomography (PET), many of which are underpowered due to their inherent expense and technical difficulty. For example, a formal analysis of the statistical power of [18F]fluorodeoxyglucose PET oncology studies highlighted the relationship between precision of the endpoint and the necessary group size for obtaining sensitivity to a 20% treatment effect (Doot et al., 2012). And yet, if sufficiently powered, molecular imaging can be the only way to obtain information about disease pathophysiology without confounds arising from ante mortem treatment and post mortem changes in the biomarker. The recent meta-analysis by Kambeitz and Howes (2015) reporting on the availability of plasma membrane serotonin transporters (SERT) in brain of patients with depressive disorders is a case in point; the summary yielded a total of 27 PET and SPECT imaging studies, comprising 514 patients and 555 healthy controls (although the composite group sizes reported in Results and Abstract differ), and revealed significantly lower SERT availability in several brain regions of the depression group. While the overall effect size (Hedges´ g) of approximately −0.3 is hardly pathognomonic of depression, the finding in such a large population confirms a long posited deficit or down-regulation of this marker of serotonin innervations (Spies et al., 2015), which furthermore could not be discerned in their additional meta-analysis of post mortem studies. The authors interpreted their results to support the importance of SERT as a molecular target for treatment of depression (despite the implication that most depressive patients have entirely normal SERT levels)...
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
|Item Type:||Journal Article|
|Subjects:||Australian and New Zealand Standard Research Classification > PSYCHOLOGY AND COGNITIVE SCIENCES (170000) > PSYCHOLOGY (170100) > Biological Psychology (Neuropsychology Psychopharmacology Physiological Psychology) (170101)|
|Divisions:||Current > QUT Faculties and Divisions > Faculty of Health
Current > Institutes > Institute of Health and Biomedical Innovation
Current > Schools > School of Psychology & Counselling
|Deposited On:||13 Oct 2016 00:38|
|Last Modified:||13 Oct 2016 21:30|
Repository Staff Only: item control page